| # | Drug | Count |
|---|---|---|
| 0 | TADALAFIL | 84 |
| 1 | ASPIRIN | 54 |
| 2 | ASPIRIN 325 MG | 54 |
| 3 | ASPIRIN 81 MG | 54 |
| 4 | CLOPIDOGREL BISULFATE | 45 |
| 5 | CLOPIDOGREL | 43 |
| 6 | BUPRENORPHINE | 31 |
| 7 | ACETAMINOPHEN | 30 |
| 8 | FUROSEMIDE | 30 |
| 9 | ZOLPIDEM TARTRATE | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUVOREXANT | 15 | 0.0012 |
| 1 | RAMELTEON | 7 | 0.0009 |
| 2 | TADALAFIL | 84 | 0.0008 |
| 3 | CANAGLIFLOZIN | 24 | 0.0008 |
| 4 | ROMIPLOSTIM | 8 | 0.0005 |
| 5 | METHYLPHENIDATE HYDROCHLORIDE | 29 | 0.0005 |
| 6 | CLOPIDOGREL BISULFATE | 45 | 0.0004 |
| 7 | INSULIN HUMAN | 17 | 0.0004 |
| 8 | PALIPERIDONE PALMITATE | 12 | 0.0004 |
| 9 | BUPRENORPHINE | 31 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 94 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 84 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 56 |
| 3 | Benzodiazepine [EPC] | 54 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 38 |
| 5 | Loop Diuretic [EPC] | 35 |
| 6 | Insulin Analog [EPC] | 33 |
| 7 | Partial Opioid Agonist [EPC] | 31 |
| 8 | Factor Xa Inhibitor [EPC] | 30 |
| 9 | Atypical Antipsychotic [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Orexin Receptor Antagonist [EPC] | 16 | 0.0009 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 84 | 0.0006 |
| 4 | Melatonin Receptor Agonist [EPC] | 8 | 0.0006 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 8 | 0.0005 |
| 6 | Chloride Channel Activator [EPC] | 5 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Progestin Antagonist [EPC] | 2 | 0.0004 |